Banzel and Anger - a phase IV clinical study of FDA data

Summary:

Anger is reported as a side effect among people who take Banzel (rufinamide), especially for people who are male, 40-49 old, also take Epidiolex, and have Partial seizures.

The phase IV clinical study analyzes which people have Anger when taking Banzel. It is created by eHealthMe based on reports of 1,559 people who have side effects when taking Banzel from the FDA, and is updated regularly.

What is Banzel?

Banzel has active ingredients of rufinamide. It is often used in epilepsy. eHealthMe is studying from 1,590 Banzel users. Check the latest studies of Banzel.

What is Anger?

Anger is found to be associated with 1,244 drugs and 1,628 conditions by eHealthMe. Check the latest studies of Anger.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,559 people reported to have side effects when taking Banzel.
Among them, 12 people (0.77%) have Anger.

Among these 12 people:

What is the gender of people who have Anger when taking Banzel? *

female: 50 %
male: 50 %

What is the age of people who have Anger when taking Banzel? *

What are other drugs people take besides Banzel? *

What are other side effects people have besides Anger? *

Aggression: 5 people, 41.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 33.33%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 25.00%
Haemoglobin Decreased: 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Blood Sodium Decreased: 3 people, 25.00%
Weakness: 1 person, 8.33%
Visual Impairment: 1 person, 8.33%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 8.33%
Psychomotor Hyperactivity (feelings of extreme restlessness): 1 person, 8.33%

What are the existing conditions these people have? *

Partial Seizures (seizures which affect only a part of the brain at onset): 3 people, 25.00%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 16.67%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 16.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Banzel and have Anger?

- Check whether Anger is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Banzel:

Banzel (1,590 reports)

Anger treatments and more:

Anger (41,215 reports)

Browse all side effects of Banzel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anger:

Anger (1,244 drugs)

Browse all the conditions that are associated with Anger:

Anger (1,628 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rufinamide (the active ingredients of Banzel) and Banzel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.